Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia

Por Giannoudis, Athina, Davies, Andrea, Lucas, Claire M., Harris, Robert J., Pirmohamed, Munir, Clark, Richard E.
Publicado em 2008

Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript

Por Lucas, Claire M., Harris, Robert J., Giannoudis, Athina, Davies, Andrea, Knight, Katy, Watmough, Sarah J., Wang, Lihui, Clark, Richard E.
Publicado em 2009